Scarica l'app Stockscreener
3.245
0.46%
0.015
Dopo l'orario di chiusura:
3.33
0.085
+2.62%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.23
Aprire:
$3.21
Volume 24 ore:
364.03K
Relative Volume:
1.24
Capitalizzazione di mercato:
$119.48M
Reddito:
-
Utile/perdita netta:
$-42.94M
Rapporto P/E:
-2.0031
EPS:
-1.62
Flusso di cassa netto:
$-33.64M
1 W Prestazione:
+0.78%
1M Prestazione:
-12.53%
6M Prestazione:
-15.05%
1 anno Prestazione:
-28.68%
Intervallo 1D:
$3.15
$3.32
Intervallo di 1 settimana:
$3.07
$3.44
Portata 52W:
$2.53
$6.85
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Nome
Pds Biotechnology Corporation
Settore
Industria
Telefono
800-208-3343
Indirizzo
303A COLLEGE ROAD EAST, PRINCETON
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-01 | Iniziato | B. Riley Securities | Buy |
| 2021-06-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-05-27 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-09 | Iniziato | Noble Capital Markets | Outperform |
| 2019-10-24 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Pds Biotechnology Corporation Borsa (PDSB) Ultime notizie
Contrasting Semiconductor Manufacturing International (OTCMKTS:SMICY) & POET Technologies (NASDAQ:POET) - Defense World
StockNews.com Initiates Coverage on Ark Restaurants (NASDAQ:ARKR) - Defense World
Jones Soda Announces Departure of President and CEO, David Knight, and Appointment of Interim CEO, Paul Norman - Defense World
Mastech Digital (NYSE:MHH) Coverage Initiated by Analysts at StockNews.com - Defense World
Head-To-Head Analysis: Edison International (NYSE:EIX) and AltC Acquisition (NYSE:ALCC) - Defense World
FS KKR Capital Corp. (NYSE:FSK) Given Consensus Rating of “Hold” by Brokerages - Defense World
StockNews.com Begins Coverage on TRX Gold (NYSE:TRX) - Defense World
Mastech Digital (NYSE:MHH) Now Covered by Analysts at StockNews.com - Defense World
PDS Biotechnology Co. (NASDAQ:PDSB) Receives $14.25 Consensus Price Target from Analysts - MarketBeat
Bowhead Specialty (NYSE:BOW) versus Horace Mann Educators (NYSE:HMN) Critical Survey - Defense World
Zacks Research Issues Negative Estimate for CSX Earnings - Defense World
Hillman Solutions (HLMN) to Announce Quarterly Earnings on Tuesday - Defense World
Evolv Technology Holdings CEO terminated, replaced by Michael Ellenbogen as Interim CEO - Defense World
Chase (NYSE:CCF) Now Covered by Analysts at StockNews.com - Defense World
PDS Biotechnology (NASDAQ:PDSB) Stock Rating Upgraded by StockNews.com - MarketBeat
HC Wainwright Reaffirms Buy Rating for PDS Biotechnology (NASDAQ:PDSB) - MarketBeat
Is There More Room To Run For This Immunotherapy Company Stock After Hitting New High? - RTTNews
PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine - The Manila Times
NY Biopharma Shares Promising Clinical Data - Streetwise Reports
Data Readouts At ASCO (MRUS, ORIC, CGEN, PDSB...) - RTTNews
H.C. Wainwright & Co. Shares Buy Rating on Biotech Co. - Streetwise Reports
PDS Biotechnology Co. (NASDAQ:PDSB) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, Spotlight on Future Potentials (2024-2034) - IndiaPolitics.com
CD47 Inhibitors Market Projected to Grow Significantly with Emerging Cancer Therapies by 2034 | DelveInsight - The Malaysian Reserve
Mass. Biotech Receives FDA Approval - Streetwise Reports
PDS Biotechnology Corporation: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
PDS Biotechnology Corporation (PDSB)’s stock price range in the last year - US Post News
Capsule Filler Machine Industry to Eyewitness Massive Growth - Elektrotransports.lv
Major Improvements In Hershey Company (HSY) Stock Need To Be Considered - Stocks Register
Biotech Alert: Searches spiking for these stocks today - TipRanks
PDS Biotechnology shares maintain Buy rating from H.C. Wainwright on positive trial results By Investing.com - Investing.com South Africa
PDS Biotechnology shares maintain Buy rating from H.C. Wainwright on positive trial results - Investing.com India
Biotech Completes Last Patient Visit in Phase2b Osteosarcoma Trial - Streetwise Reports
Investor’s Delight: PDS Biotechnology Corporation (PDSB) Closes Strong at 4.11, Up 12.60 - The Dwinnex
XTX Topco Ltd Invests $57,000 in 3D Systems Co. (NYSE:DDD) - Defense World
Locally Advanced Cervical Cancer Phase 2 Study Publishes Positive Results - Precision Vaccinations
PDS Biotech reports promising phase 2 cervical cancer trial results By Investing.com - Investing.com Canada
PDS Biotech reports promising phase 2 cervical cancer trial results - Investing.com
New Jersey Biotech Reports Positive Survival Data - Streetwise Reports
This trade activity should not be overlooked: PDS Biotechnology Corporation (PDSB) - SETE News
PDS Biotechnology (NASDAQ:PDSB) Given "Buy" Rating at HC Wainwright - MarketBeat
PDS Biotechnology’s Versamune® HPV Shows Promise in Phase 2 Trial - TipRanks
PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation - The Manila Times
PDSB’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
A venture capital company on a huge discount - Investors Chronicle
PDSB’s current quarter earnings: What analysts forecast? - US Post News
Three North Jersey startup tech firms get aid through state program - NorthJersey.com
Three North Jersey startup tech firms get state financing for R&D and salaries - Daily Record
What's Going On With Vistra Stock? - MSN
PDS Biotechnology: Continuing The Holding Pattern (NASDAQ:PDSB) - Seeking Alpha
Pds Biotechnology Corporation Azioni (PDSB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):